LJ

Lakhya Jeet Kalita

Active Director Director DIN 10854004
DIN 10854004 First appointment Nov 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Lakhya Jeet Kalita

Data last updated:

Lakhya Jeet Kalita is a Director at Algieba Pharmaceuticals Private Limited (since 2024). The company operates in Paper.

DIN 10854004
Primary Designation Director
Industry Paper
First Appointment 28 Nov 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Nov 20242024Active

Board colleagues of Lakhya Jeet Kalita

NameDINCompanyDesignation
Tilottama Kalita10854003Algieba Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Algieba Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Lakhya Jeet Kalita

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lakhya Jeet Kalita

Lakhya Jeet Kalita currently holds 1 directorship: Algieba Pharmaceuticals Private Limited (Director, since 28 Nov 2024).

Lakhya Jeet Kalita was first appointed on 28 Nov 2024 as Director at Algieba Pharmaceuticals Private Limited.

The current boards of Lakhya Jeet Kalita's companies include Tilottama Kalita (Algieba Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available